Tempest Therapeutics Inc

NASDAQ TPST

Data sourced from iex and EODHD
Download Data

Tempest Therapeutics Inc Income Statement 2011 - 2024

This table shows the Income Statement for Tempest Therapeutics Inc going from 2011 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-09-30
Revenue
M 0 0 0 0 0 0 0 0 0 0 0 0 0 - 0 0 - - - - 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10 - - - - - - - - - - - -
Cost of Revenue
M 0 0 1 0 1 1 - - - - - - - - - - - - - - 4 0 0 0 0 0 0 0 1 2 1 1 1 1 0 0 - - - - - - - - - - - - -
Gross Profit
M 0 0 -1 0 -1 -1 - - - - - - - - - - - - - - 0 0 0 0 0 0 0 0 -1 -1 -1 -1 -1 -1 0 0 10 - - - - - - - - - - - -
Operating Expenses
M 8 7 6 7 7 8 - - - - - - - - - - - - - - 9 6 5 7 8 9 16 13 16 18 17 20 19 17 17 17 28 - - - - - - - - - - - -
Selling, General, and Administrative Expenses (SG&A)
M 4 3 2 3 3 3 3 3 3 3 3 3 2 1 1 1 5 4 4 4 1 4 3 4 5 5 11 7 11 13 11 14 15 13 13 11 11 7 5 3 4 4 3 2 2 2 2 2 0
Research and Development (R&D) Expenses
M 4 4 4 4 5 6 6 6 5 5 5 4 4 3 4 4 8 8 7 6 8 2 2 3 4 4 5 6 5 5 6 6 5 4 4 6 7 5 5 5 7 3 3 3 2 2 1 1 0
Other Operating Expenses
M 0 0 -1 0 -1 -1 - - - - - - - - - - - - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10 - - - - - - - - - - - -
Costs and Expenses
M 8 7 6 7 7 8 - - - - - - - - - - - - - - 6 6 5 7 8 9 15 13 14 16 16 19 18 16 17 17 - - - - - - - - - - - - -
Operating Income
M -8 -8 -7 -7 -8 -9 -9 -9 -8 -7 -8 -7 -5 -4 -5 -5 -12 -13 -12 -10 -9 -6 -5 -7 -8 -9 -16 -13 -17 -19 -18 -21 -20 -18 -17 -17 -18 -12 -10 -8 -11 -7 -6 -5 -4 -3 -3 -3 -1
Interest Expense
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - 1 - - - 0 0 0 0 - 0 0 0 - - - - - - - - -
Non-operating Income/Expense
M 0 0 0 0 0 0 0 0 0 -1 0 0 0 -3 -1 -5 0 0 0 0 3 0 -3 0 0 0 -2 -2 -6 0 0 0 0 0 0 0 -1 -1 0 0 0 0 0 0 0 0 - - -
EBT
M -8 -7 -7 -8 -8 -9 -9 -9 -8 -8 -8 -7 -5 -4 -5 -5 -12 -13 -12 -10 -6 -6 -8 -7 -8 -9 -18 -15 -23 -19 -19 -22 -21 -18 -17 -17 -19 -13 -10 -8 -11 -7 -6 -5 -4 -3 -3 -3 -
Income Tax Provision
M - 0 0 0 0 1 0 0 0 1 0 0 0 -3 -1 -6 0 0 0 0 3 0 -3 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 -1 0 0 0 0 0 0 - - - - -
Income after Tax
M - -7 -7 -8 -8 -10 -9 -10 -9 -8 -8 -7 -6 -1 -4 0 -12 -13 -12 -10 -9 -6 -5 -7 -9 -9 -18 -15 -23 -19 -19 -22 -21 -18 -17 -17 -18 -12 -10 -8 -11 -7 -6 -5 - - - - -
Non-Controlling Interest
M - - - 0 0 -2 0 0 0 0 0 0 0 - 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Net Income
M - - - -8 -8 -8 -9 -9 -8 -8 -8 -7 -5 - -5 -5 -4 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 22,234,225.00 21,520,899.00 14,121,805.00 14,102,211.00 13,763,173.00 11,548,907.00 13,635,927.00 11,573,432.00 7,167,255.00 6,717,655.00 6,717,655.00 925,432.00 6,635,303.00 925,432.00 6,635,303.00 6,635,303.00 925,432.00 925,432.00 894,708.00 894,708.00 894,708.00 159,067.00 159,067.00 158,783.00 158,783.00 158,783.00 158,507.00 158,507.00 158,507.00 158,507.00 133,494.00 133,494.00 121,245.00 121,245.00 120,881.00 120,881.00 120,881.00 120,881.00 104,649.00 104,649.00 104,649.00 104,649.00 104,649.00 59,311.00 56,053.60 33,057.93 6,880.00 33,057.93 4,351.07
EBITDA
M -8 -7 -7 -7 -7 -8 -8 -9 -8 -7 -8 -7 -5 -4 -5 -5 -12 -12 -12 -10 -7 -6 -8 -7 -8 -9 -18 -14 -22 -19 -18 -21 -20 -18 -17 -17 -19 -13 -10 -8 -11 -7 -6 -5 -4 -3 -3 -3 -1
Depreciation and Amortization
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 - - - - -
EBIT
M -8 -8 -7 -7 -8 -9 -9 -9 -8 -7 -8 -7 -5 -4 -5 -6 -12 -13 -12 -10 -6 -6 -8 -7 -8 -9 -18 -15 -23 -19 -19 -22 -21 -18 -17 -17 -19 -13 -10 -8 -11 -7 -6 -5 - - - - -
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% - 6.30 1.30 -2.12 -5.23 -9.81 -1.97 -4.30 -3.89 -7.31 -0.78 -0.04 -7.54 70.35 17.31 109.45 0.21 0.31 1.02 0.24 -42.05 -2.92 34.93 6.51 -0.40 -0.12 -0.07 -0.06 0.07 -0.48 -0.27 -0.35 -0.37 0.84 1.81 2.28 3.18 4.05 3.01 2.10 -0.12 -0.49 -0.42 -0.35 - - - - -
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - - 0 0 0 0 0 0 0 0 0 0 - 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Gross Profit Margin
% - - - - - - - - - - - - - - - - - - - - 0.20 20.00 33.33 -67.16 -139.56 48.21 -226.19 -326.98 -1,084.30 -691.37 -552.38 -705.48 -637.58 -1,153.33 -286.67 -133.33 100.00 - - - - - - - - - - - -
Operating Income Margin
% - - - - - - - - - - - - - - - - - - - - -256.74 -10,627.27 -6,187.65 -10,283.58 -9,336.26 -16,151.79 -18,973.81 -20,792.06 -14,023.14 -9,626.40 -9,651.32 -14,684.25 -12,891.72 -23,696.00 -57,246.67 -112,086.67 -187.87 - - - - - - - - - - - -
Net Income Margin
% - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EBITDA Ratio
% - - - - - - - - - - - - - - - - - - - - -198.06 -10,094.55 -9,292.59 -10,507.46 -8,961.54 -16,064.29 -21,051.19 -22,896.83 -18,236.36 -9,452.28 -9,500.00 -14,506.16 -12,731.21 -23,445.33 -57,690.00 -113,193.33 -192.11 - - - - - - - - - - - -
EBIT Ratio
% - - - - - - - - - - - - - - - - - - - - -181.15 -10,325.45 -9,509.88 -11,000.00 -9,334.07 -16,707.14 -21,634.52 -23,628.57 -18,726.45 -9,745.69 -9,797.88 -14,851.37 -13,073.89 -23,896.00 -58,300.00 -114,706.67 -194.04 - - - - - - - - - - - -
EBT Ratio
% - - - - - - - - - - - - - - - - - - - - -180.73 -10,325.45 -9,509.88 -11,000.00 -9,334.07 -16,707.14 -21,634.52 -23,628.57 -18,726.45 -9,745.69 -9,797.88 -14,851.37 -13,073.89 -23,896.00 -58,300.00 -114,706.67 -194.04 - - - - - - - - - - - -

StockViz Staff

September 20, 2024

Any question? Send us an email